AU1888999A - Polymeric carrier - Google Patents

Polymeric carrier

Info

Publication number
AU1888999A
AU1888999A AU18889/99A AU1888999A AU1888999A AU 1888999 A AU1888999 A AU 1888999A AU 18889/99 A AU18889/99 A AU 18889/99A AU 1888999 A AU1888999 A AU 1888999A AU 1888999 A AU1888999 A AU 1888999A
Authority
AU
Australia
Prior art keywords
polymeric carrier
polymeric
carrier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU18889/99A
Other languages
English (en)
Inventor
Avraham J. Domb
Zeev Zehavi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Efrat Biopolymers Ltd
Original Assignee
Efrat Biopolymers Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Efrat Biopolymers Ltd filed Critical Efrat Biopolymers Ltd
Publication of AU1888999A publication Critical patent/AU1888999A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
AU18889/99A 1998-01-14 1999-01-14 Polymeric carrier Abandoned AU1888999A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL122933 1998-01-14
IL12293398A IL122933A (en) 1998-01-14 1998-01-14 Polymeric carrier for delivery of a bioactive molecule
PCT/IL1999/000023 WO1999036100A2 (fr) 1998-01-14 1999-01-14 Excipient polymere

Publications (1)

Publication Number Publication Date
AU1888999A true AU1888999A (en) 1999-08-02

Family

ID=11071088

Family Applications (1)

Application Number Title Priority Date Filing Date
AU18889/99A Abandoned AU1888999A (en) 1998-01-14 1999-01-14 Polymeric carrier

Country Status (6)

Country Link
EP (1) EP0967998A2 (fr)
JP (1) JP2001515522A (fr)
AU (1) AU1888999A (fr)
CA (1) CA2283648C (fr)
IL (1) IL122933A (fr)
WO (1) WO1999036100A2 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2831900A (en) 1999-02-19 2000-09-04 Universiteit Utrecht Stereocomplex hydrogels
JP2002537343A (ja) * 1999-02-23 2002-11-05 アイシス・ファーマシューティカルス・インコーポレーテッド 多重粒子製剤
WO2002083166A1 (fr) * 2001-04-10 2002-10-24 Santen Pharmaceutical Co., Ltd. Complexes de polymeres d'interferons et leur utilisation medicinale
DE10154924A1 (de) * 2001-11-08 2003-05-28 Medinnova Ges Med Innovationen Bioabbaubare Kopolymere
EA008244B1 (ru) * 2002-05-03 2007-04-27 Янссен Фармацевтика Н.В. Полимерные микроэмульсии
JP4877225B2 (ja) * 2005-02-18 2012-02-15 日油株式会社 ポリオキシアルキレン誘導体
EP1902084A2 (fr) * 2005-06-01 2008-03-26 Yissum Research Development Company, of The Hebrew University of Jerusalem Polymeres biodegradables a chiralite predeterminee
US7794838B2 (en) * 2006-02-03 2010-09-14 National University Corporation Hokkaido University Nanodisk comprising block copolymer
PL2135887T3 (pl) 2008-06-18 2011-05-31 Inst Biopolimerow I Wlokien Chemicznych Sposób wytwarzania stereokompleksu polikwasu mlekowego w postaci proszku
WO2012005376A1 (fr) * 2010-07-09 2012-01-12 国立大学法人 東京大学 Composition d'administration d'acides nucléiques, composition d'excipient, composition pharmaceutique contenant la composition d'administration d'acides nucléiques ou la composition d'excipient et méthode d'administration d'acides nucléiques
CN108559084B (zh) * 2018-04-13 2020-12-04 华东理工大学 一种聚乳酸基疏水薄膜的制备方法
CN109908106A (zh) * 2019-03-04 2019-06-21 北京化工大学 一种可供静脉注射的甲氨蝶呤纳米胶囊及其制备方法
JP7050734B2 (ja) * 2019-09-30 2022-04-08 鳥居薬品株式会社 舌下アレルゲン免疫療法におけるフィルム製剤
CN115785471B (zh) * 2022-12-16 2023-08-08 华中科技大学 一种二氧化碳基超分子聚合物及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6136321A (ja) * 1984-07-27 1986-02-21 Daicel Chem Ind Ltd 新規なポリマ−およびその樹脂組成物
US4902515A (en) * 1988-04-28 1990-02-20 E. I. Dupont De Nemours And Company Polylactide compositions
CA2046830C (fr) * 1990-07-19 1999-12-14 Patrick P. Deluca Systeme d'administration des medicaments comprenant une interaction entre une proteine ou une polypeptide et un polymere hydrophobe biodegradable

Also Published As

Publication number Publication date
CA2283648C (fr) 2007-04-17
IL122933A (en) 2005-03-20
JP2001515522A (ja) 2001-09-18
IL122933A0 (en) 1998-08-16
WO1999036100A2 (fr) 1999-07-22
CA2283648A1 (fr) 1999-07-22
WO1999036100A3 (fr) 1999-09-23
EP0967998A2 (fr) 2000-01-05

Similar Documents

Publication Publication Date Title
AU6397399A (en) Multi-pack carrier
AU3478999A (en) Component carrier
AU3485999A (en) Neo-tryptophan
AU1328800A (en) Polymeric supported catalysts
AU1888999A (en) Polymeric carrier
AU1124099A (en) Double ended carrier
AU3437799A (en) City-car
AU3522399A (en) Carvedilol-galenics
AU3253699A (en) Myxochelines
AU5407599A (en) Sphingolipid-desaturase
GB9812832D0 (en) Improved carrier
AU3718399A (en) Ski carrier
AU2609599A (en) Sensor-coupling
AU7273098A (en) Hyperstructure-forming carriers
AU3204999A (en) Futureball
AU2069199A (en) Codelets
AU5223199A (en) Bathtub-bathseat
AU3347599A (en) Aeromobile
AU2840799A (en) 1-phosphanorbornadienes
AU3819799A (en) Methoximinomethyloxathiazines
AUPP218698A0 (en) Carrier
AU1779099A (en) Heterocyclyl-derivatives
AU4768799A (en) Bookcover
AU5466396A (en) Multitray carrier
AUPO237996A0 (en) Carrier

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase